# PAHTCH Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure (Carvedilol)

> **NCT01586156** · NA · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 30 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** Carvedilol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01586156
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-12-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01586156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01586156, "PAHTCH Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure (Carvedilol)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01586156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*